📄 cell biology

The Orai3 channel and AHNAK2 scaffold protein promote the activation of primary human muscle stem cells in vitro

This study reveals that the Orai3 calcium channel and its scaffold partner AHNAK2 promote the activation of primary human muscle stem cells through distinct, calcium-independent mechanisms, with Orai3 directly influencing cell fate and AHNAK2 facilitating activation via signals from myotubes.

Original authors: Tollance, A., Fourgeaud, M., Koenig, S., Frieden, M.

Published 2026-09-24

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Tollance, A., Fourgeaud, M., Koenig, S., Frieden, M.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The human body possesses a remarkable, built-in repair crew dedicated to fixing damaged muscle. When a muscle is injured, a special group of dormant cells, known as muscle stem cells, wakes up to begin the work of regeneration. These cells, which usually sit quietly waiting for a signal, spring into action, multiply, and then either fuse together to form new muscle fibers or return to their quiet state to ensure there are enough helpers left for future injuries. Understanding exactly how these cells decide to wake up and start working is crucial, not only for understanding how the body heals itself but also for figuring out what goes wrong when that healing process fails. For a long time, scientists have known that chemical signals from the surrounding environment trigger this awakening, but the specific molecular switches inside the cells that control this transition have remained a mystery, particularly in humans.

A team of researchers at the University of Geneva has now uncovered two key proteins that act as essential switches for this process in human muscle cells. They focused on a specific type of laboratory-grown cell that mimics these dormant stem cells, allowing them to watch the activation process in real time. The scientists discovered that a protein called Orai3, which is found in high amounts in these dormant cells, is necessary for them to wake up. Surprisingly, this protein performs its job without using its usual function as a channel for calcium, a mineral that typically acts as a signal inside cells. Instead, Orai3 works through a different, calcium-independent mechanism to push the cells out of their resting state and into the cycle of growth.

While investigating how Orai3 works, the researchers looked for other proteins that might be working alongside it. They identified a large structural protein called AHNAK2, which acts like a scaffold to hold other molecules in place. This protein is found in high quantities in the mature muscle fibers that form during the repair process. The team found that AHNAK2 also plays a vital role in waking up the dormant stem cells, but it does so in a completely different way than Orai3. While Orai3 acts directly on the stem cells themselves, AHNAK2 works indirectly. It influences the mature muscle fibers, which then send signals back to the stem cells to encourage them to wake up. If the researchers removed AHNAK2, the stem cells could still wake up if they were separated from the mature muscle fibers, proving that the defect was caused by the state of the surrounding muscle tissue rather than a failure within the stem cells themselves.

The study also revealed that these two proteins have distinct effects on how muscle cells develop. When the researchers reduced the amount of Orai3, the cells tended to skip the dormant phase and move more quickly toward becoming muscle fibers. In contrast, reducing AHNAK2 slowed down the formation of new muscle fibers and caused the existing fibers to grow larger than usual. This suggests that while both proteins are needed for the muscle repair system to function correctly, they operate through separate pathways. One acts as a direct trigger for the stem cells, while the other helps maintain the environment provided by the mature muscle tissue that supports that trigger.

These findings provide a clearer picture of the molecular machinery behind muscle regeneration in humans. By showing that Orai3 and AHNAK2 are both required for proper activation but function through different mechanisms, the research highlights the complexity of how stem cells interact with their environment. The work rules out the idea that Orai3 acts as a calcium channel in this specific context, confirming that its role is unique and separate from its traditional function. Similarly, it clarifies that the influence of AHNAK2 is not due to a chemical released into the fluid around the cells, but rather a direct interaction between the mature muscle fibers and the stem cells. This detailed understanding of the specific roles these proteins play offers new insights into the fundamental processes that allow our muscles to repair themselves, potentially opening doors for future research into how these mechanisms might be supported or restored in cases of muscle disease.

Technical Summary: The Orai3 Channel and AHNAK2 Scaffold Protein Promote the Activation of Primary Human Muscle Stem Cells In Vitro

Problem Statement
Skeletal muscle regeneration relies on the activation of muscle stem cells (MuSC), which transition from a quiescent state to proliferation upon injury. While the regulation of murine MuSC is relatively well-characterized, the molecular mechanisms governing human MuSC activation and self-renewal remain poorly understood. A significant challenge in studying human MuSC is that the extraction process itself activates the cells, altering their gene expression and obscuring the molecular signatures of true quiescence. Previous work by the authors established an in vitro model using primary human myoblasts that differentiate into myotubes and "reserve cells" (RC)—quiescent, stem cell-like cells that can be re-activated by serum stimulation. While it was previously known that RC activation is independent of calcium ( $Ca^{2+}$ ) signaling despite the presence of a robust $Ca^{2+}$ response, the specific molecular drivers of this activation remained unclear.

Methodology
The study utilized primary human myoblasts derived from semitendinosus muscle samples. The experimental workflow involved:

Cell Culture Model: Differentiation of myoblasts into myotubes and RCs using a serum-free differentiation medium, followed by re-activation with growth medium (GM) containing serum.
Gene Silencing: Transfection of myoblasts with specific siRNAs targeting Orai1, Orai2, Orai3, and AHNAK2 to assess their functional roles.
Functional Assays:
- Activation: Quantified via EdU incorporation in MEF2C-negative nuclei (RCs).
- Differentiation: Assessed via immunofluorescence for $\alpha$ -actinin and MEF2C expression.
- Calcium Signaling: Measured Store-Operated Calcium Entry (SOCE) and serum-induced $Ca^{2+}$ oscillations using Fura-2 AM ratiometric imaging and $Mn^{2+}$ quenching assays.
Protein Interaction Screening: Employed BioID (biotin identification) using an Orai3-BirA fusion protein to identify proximal protein partners in myoblasts, followed by mass spectrometry (LC-ESI-MS/MS).
Conditioned Media Experiments: Tested whether soluble factors secreted by myotubes mediated RC activation by applying conditioned media from siRNA-transfected cells to adherent RCs.

Key Contributions and Results

Orai3 is Essential for RC Activation but Calcium-Independent:
RT-qPCR revealed that Orai3 mRNA is predominantly expressed in RCs compared to myoblasts and myotubes. Knockdown of Orai3 resulted in a ~30% reduction in RC activation (EdU incorporation). Crucially, despite Orai3's high expression in RCs, its depletion did not alter SOCE amplitude or serum-induced $Ca^{2+}$ oscillations. This confirms that Orai3 promotes RC activation through a mechanism distinct from its canonical function as a calcium channel.
Identification of AHNAK2 as a Partner:
BioID screening identified AHNAK2, a large scaffold protein, as a potential interactor of Orai3. AHNAK2 is highly expressed in myotubes and present in RCs. Similar to Orai3, silencing AHNAK2 reduced RC activation by approximately 60%.
Distinct Mechanisms of Action:
While both proteins are necessary for RC activation, they function through different pathways:
- Orai3 acts cell-autonomously: The defect in RC activation caused by Orai3 knockdown persisted even when myotubes were removed prior to stimulation, indicating Orai3 acts directly on the RCs.
- AHNAK2 acts via myotube signaling: The activation defect caused by AHNAK2 knockdown was fully restored when myotubes were removed before RC stimulation. Furthermore, conditioned media from AHNAK2-depleted cells did not inhibit RC activation, suggesting AHNAK2 influences RCs via direct cell-cell contact (juxtacrine) rather than soluble paracrine factors.
Differential Roles in Differentiation:
Depletion of these proteins affected the differentiation process differently:
- Orai3 depletion: Led to an increase in MEF2C-positive nuclei, suggesting a shift away from the RC fate toward differentiation.
- AHNAK2 depletion: Delayed differentiation (reduced MEF2C at 24h) and resulted in significantly larger myotubes, suggesting a role in structural integrity or fusion dynamics.

Significance
The paper claims to provide new insights into the molecular machinery governing human MuSC quiescence and activation. The primary significance lies in demonstrating that Orai3 facilitates RC activation in a non-canonical, calcium-independent manner. Additionally, the study identifies AHNAK2 as a critical scaffold protein that links myotube properties to RC activation, likely through juxtacrine signaling. The authors suggest that these findings reveal distinct pathways for RC fate determination: Orai3 directly influences RC intrinsic fate, while AHNAK2 modulates the microenvironment provided by myotubes. The authors note that these mechanisms may have broader implications for understanding stem cell quiescence and could potentially offer new targets for conditions involving stem cell dysfunction, such as cancer stem cells, given the known roles of Orai3 and AHNAK2 in various malignancies. However, the paper remains modest, stating that the specific signaling pathways and the nature of the juxtacrine interaction require further investigation.

More like this